| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10101384 | The American Journal of Surgery | 2005 | 5 Pages |
Abstract
Increased preoperative platelet count is associated with adverse survival outcome in patients undergoing resection for pancreatic cancer. Antiplatelet medications warrant further study in an attempt to improve survival in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Kimberly M. M.D., Christinnah M.D., Gerard V. (F.R.C.S(C)., F.A.C.S.), Sherri M.D., Margo M.D.,